This inventor holds 1 USPTO granted patent. Top assignee: Hiroshima Institute of Life Sciences. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Kazuaki Chayama: Innovator in Hepatitis B Research
Introduction
Kazuaki Chayama is a prominent inventor based in Hiroshima, Japan. He has made significant contributions to the field of medical research, particularly in the fight against viral infections.
Latest Patents
Chayama holds a patent for a "Human NTCP-Binding Antibody Capable of Inhibiting Infection of Hepatitis B Virus (HBV) to Human Hepatocytes." This innovative work is crucial in developing therapies for hepatitis B, a virus that affects millions worldwide. He has 1 patent to his name.
Career Highlights
Chayama is affiliated with the Hiroshima Institute of Life Sciences, where he conducts his research. His work focuses on understanding the mechanisms of viral infections and developing effective treatments.
Collaborations
Chayama collaborates with notable colleagues, including Akiko Sugimoto and Yushi Futamura. Their combined expertise enhances the research efforts at the Hiroshima Institute of Life Sciences.
Conclusion
Kazuaki Chayama's contributions to hepatitis B research exemplify the impact of innovative thinking in medicine. His work continues to pave the way for advancements in treatment and prevention strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile